Citizens Financial Group Inc Bluebird Bio, Inc. Transaction History

Citizens Financial Group Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 12, 2020	SELL	$34.44 - $43.75 $3,650 - $4,637	-106 Closed	0 $0
Q2 2020 Aug 12, 2020	SELL	$27.12 - $45.97 $1,301 - $2,206	-48 Reduced 31.17%	106 $6,000
Q1 2020 May 08, 2020	BUY	$26.16 - $63.5 $2,537 - $6,159	97 Added 170.18%	154 $7,000
Q4 2019 Feb 07, 2020	BUY	$46.96 - $61.67 $2,676 - $3,515	57 New	57 $5,000

151

63.4M

264K

428K

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $28.5M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

Get notified when there are updates to the investment portfolio of Citizens Financial Group Inc, based on Form 13F filings with the SEC.

Stay updated on Citizens Financial Group Inc with notifications on news.